SENP1 expression was significantly linked to adverse tumor features including advanced stage, high Gleason grade, and presence of lymph node metastases, preoperative PSA levels, and early biochemical recurrence in our analysis. Here, SENP1 is linked to metastatic malignant neoplasm in the lymph nodes.